LeMaitre Vascular, Inc. — Rendiconto Finanziario Trimestrale (NASDAQ:LMAT) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi

Trimestrale Annuale

Market Capitalization 2.16 B
Employee 655
Founded 1983
CEO George W Lemaitre
Website www.lemaitre.com
Headquarter Massachusetts, United States
FIGI BBG000LY1HS2
Industry Strumenti e Forniture Mediche

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

Rapporto prezzo/utili

40.14

Rapporto prezzo/fatturato

9.92

Dividendi per azione

0.25

Rendimento da dividendi %

1.33

Notizie

Dividend Champion, Contender, And Challenger Highlights: Week Of May 31

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why

Dividend Champion, Contender, And Challenger Highlights: Week Of May 17

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround

3 Reasons Growth Investors Will Love LeMaitre (LMAT)

LeMaitre (LMAT) Upgraded to Buy: Here's Why

Citizens alza il target su LeMaitre Vascular per le prospettive sui margini

LeMaitre Vascular, Inc. (LMAT) Q1 2026 Earnings Call Transcript

Relazione sugli utili: LeMaitre Vascular supera le attese nel Q1 2026

LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry